Interact to see
Advertisement
Advertisement
ADNRX vs FSMAX
ADNRX vs FSMAX Comparison
Open Charts ADNRX vs FSMAX
American Beacon ARK Transfmt Innov R6
Price$20.67
Change+$0.71 (+3.56%)
VolumeN/A
Net Assets209.36M
Fidelity Extended Market Index
Price$94.47
Change+$0.80 (+0.85%)
VolumeN/A
Net Assets39.17B
ADNRX vs FSMAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
ADNRX vs. FSMAX commentary
Jul 18, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADNRX is a Hold and FSMAX is a Hold.
FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 39.2B vs. ADNRX (209M). FSMAX pays higher dividends than ADNRX: FSMAX (0.47) vs ADNRX (0.00). ADNRX was incepted earlier than FSMAX: ADNRX (5 years) vs FSMAX (14 years). ADNRX (1.13) is less costly to investors than FSMAX (0.04). ADNRX is a more actively managed with annual turnover of: 38.00 vs. FSMAX (9.00). ADNRX (0) and FSMAX (0) have matching initial minimum investment requirements. ADNRX annual gain was more profitable for investors over the last year : 52.66 vs. FSMAX (11.27).
| ADNRX | FSMAX | ADNRX / FSMAX | |
| Total Expense Ratio | 1.00 | 0.04 | 2,857% |
| Annual Report Gross Expense Ratio | 1.13 | 0.04 | 3,229% |
| Fund Existence | 5 years | 14 years | - |
| Gain YTD | 32.585 | 3.950 | 825% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 209M | 39.2B | 1% |
| Annual Yield % from dividends | 0.00 | 0.47 | - |
| Returns for 1 year | 52.66 | 11.27 | 467% |
| Returns for 3 years | 60.48 | 52.72 | 115% |
| Returns for 5 years | N/A | 57.86 | - |
| Returns for 10 years | N/A | 78.23 | - |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement